230 related articles for article (PubMed ID: 18348659)
1. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
Mazurek A; Kuc P; Terlikowski S; Laudanski T
Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer.
Fujiwaki R; Hata K; Iida K; Koike M; Miyazaki K
Gynecol Oncol; 1998 Mar; 68(3):247-52. PubMed ID: 9570975
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
Sivridis E; Giatromanolaki A; Anastasiadis P; Georgiou L; Gatter KC; Harris AL; Bicknell R; Koukourakis MI;
J Pathol; 2002 Apr; 196(4):416-22. PubMed ID: 11920737
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
8. The association between p53 expression, stage and histological features in endometrial cancer.
Ragni N; Ferrero S; Prefumo F; Muschiato B; Gorlero F; Gualco M; Fulcheri E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):111-6. PubMed ID: 15894417
[TBL] [Abstract][Full Text] [Related]
9. [Expression of p53 protein in women with endometrial cancer].
Ivanov S; Khadzhiolov N; Ivanov S
Akush Ginekol (Sofiia); 2001; 40(4):14-5. PubMed ID: 11803862
[TBL] [Abstract][Full Text] [Related]
10. p53 as a prognostic indicator in endometrial cancer.
Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE
Gynecol Oncol; 1996 May; 61(2):245-8. PubMed ID: 8626141
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 and p53 expression in stage I endometrial carcinoma.
Giatromanolaki A; Sivridis E; Koukourakis MI; Harris AL; Gatter KC
Anticancer Res; 1998; 18(5B):3689-93. PubMed ID: 9854478
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy.
Graesslin O; Chantot-Bastaraud S; Lorenzato M; Birembaut P; Quéreux C; Daraï E
Ann Surg Oncol; 2008 Feb; 15(2):484-92. PubMed ID: 18071824
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
14. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer.
Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Suzuki M; Terao T
Hum Pathol; 2002 Nov; 33(11):1105-13. PubMed ID: 12454815
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables.
Erdem O; Erdem M; Dursun A; Akyol G; Erdem A
Int J Gynecol Pathol; 2003 Jul; 22(3):254-60. PubMed ID: 12819392
[TBL] [Abstract][Full Text] [Related]
16. Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas.
Matsuura T; Kuratate I; Teramachi K; Osaki M; Fukuda Y; Ito H
Cancer Res; 1999 Oct; 59(19):5037-40. PubMed ID: 10519420
[TBL] [Abstract][Full Text] [Related]
17. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis and Bcl-2 protein expression in patients with endometrial carcinoma.
Mazurek A; Pierzynski P; Niklinska W; Chyczewski L; Laudanski T
Neoplasma; 2002; 49(3):149-54. PubMed ID: 12097999
[TBL] [Abstract][Full Text] [Related]
19. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
[TBL] [Abstract][Full Text] [Related]
20. The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.
Gunningham SP; Currie MJ; Morrin HR; Tan EY; Turley H; Dachs GU; Watson AI; Frampton C; Robinson BA; Fox SB
J Pathol; 2007 Jul; 212(3):335-44. PubMed ID: 17487938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
